MICHAEL LEWIS to Oncogene Proteins, Fusion
This is a "connection" page, showing publications MICHAEL LEWIS has written about Oncogene Proteins, Fusion.
Connection Strength
0.208
-
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer. Cancer Res. 2021 12 15; 81(24):6259-6272.
Score: 0.170
-
Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer. Proc Natl Acad Sci U S A. 2020 05 05; 117(18):9912-9921.
Score: 0.038